141 related articles for article (PubMed ID: 21811303)
1. Discrepancies in reporting the CAG repeat lengths for Huntington's disease.
Quarrell OW; Handley O; O'Donovan K; Dumoulin C; Ramos-Arroyo M; Biunno I; Bauer P; Kline M; Landwehrmeyer GB;
Eur J Hum Genet; 2012 Jan; 20(1):20-6. PubMed ID: 21811303
[TBL] [Abstract][Full Text] [Related]
2. Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey.
Palomaki GE; Richards CS
Genet Med; 2012 Jan; 14(1):69-75. PubMed ID: 22237433
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.
Ramos EM; Gillis T; Mysore JS; Lee JM; Alonso I; Gusella JF; Smoller JW; Sklar P; MacDonald ME; Perlis RH
Bipolar Disord; 2015 Jun; 17(4):403-8. PubMed ID: 25726852
[TBL] [Abstract][Full Text] [Related]
4. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the IT15 gene in Huntington's disease families].
Genetika; 2004 Aug; 40(8):1123-30. PubMed ID: 15523851
[TBL] [Abstract][Full Text] [Related]
6. Correlation of CAG repeat length between the maternal and paternal allele of the Huntingtin gene: evidence for assortative mating.
Nopoulos P; Epping EA; Wassink T; Schlaggar BL; Perlmutter J
Behav Brain Funct; 2011 Oct; 7():45. PubMed ID: 22008211
[TBL] [Abstract][Full Text] [Related]
7. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
8. Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.
Lee JM; Galkina EI; Levantovsky RM; Fossale E; Anne Anderson M; Gillis T; Srinidhi Mysore J; Coser KR; Shioda T; Zhang B; Furia MD; Derry J; Kohane IS; Seong IS; Wheeler VC; Gusella JF; MacDonald ME
Hum Mol Genet; 2013 Aug; 22(16):3227-38. PubMed ID: 23595883
[TBL] [Abstract][Full Text] [Related]
9. Development of genomic reference materials for Huntington disease genetic testing.
Kalman L; Johnson MA; Beck J; Berry-Kravis E; Buller A; Casey B; Feldman GL; Handsfield J; Jakupciak JP; Maragh S; Matteson K; Muralidharan K; Richie KL; Rohlfs EM; Schaefer F; Sellers T; Spector E; Richards CS
Genet Med; 2007 Oct; 9(10):719-23. PubMed ID: 18073586
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the Huntington's disease gene in New Zealand.
Whitefield JE; Williams L; Snow K; Dixon J; Winship I; Stapleton PM; Faull RM; Love DR
N Z Med J; 1996 Feb; 109(1015):27-30. PubMed ID: 8606810
[TBL] [Abstract][Full Text] [Related]
11. No association of the SCA1 (CAG)31 allele with Huntington's disease, myotonic dystrophy type 1 and spinocerebellar ataxia type 3.
Hellenbroich Y; Kaulich M; Opitz S; Schwinger E; Zühlke C
Psychiatr Genet; 2004 Jun; 14(2):61-3. PubMed ID: 15167689
[TBL] [Abstract][Full Text] [Related]
12. EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease.
Losekoot M; van Belzen MJ; Seneca S; Bauer P; Stenhouse SA; Barton DE;
Eur J Hum Genet; 2013 May; 21(5):480-6. PubMed ID: 22990145
[TBL] [Abstract][Full Text] [Related]
13. Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls.
Jiang H; Sun YM; Hao Y; Yan YP; Chen K; Xin SH; Tang YP; Li XH; Jun T; Chen YY; Liu ZJ; Wang CR; Li H; Pei Z; Shang HF; Zhang BR; Gu WH; Wu ZY; Tang BS; Burgunder JM;
Eur J Neurol; 2014 Apr; 21(4):637-42. PubMed ID: 24471773
[TBL] [Abstract][Full Text] [Related]
14. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
15. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation.
Mangiarini L; Sathasivam K; Mahal A; Mott R; Seller M; Bates GP
Nat Genet; 1997 Feb; 15(2):197-200. PubMed ID: 9020849
[TBL] [Abstract][Full Text] [Related]
16. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
17. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
[TBL] [Abstract][Full Text] [Related]
18. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
[TBL] [Abstract][Full Text] [Related]
19. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
Panegyres PK; Goh JG
J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
[TBL] [Abstract][Full Text] [Related]
20. Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.
Jimenez-Sanchez M; Licitra F; Underwood BR; Rubinsztein DC
Cold Spring Harb Perspect Med; 2017 Jul; 7(7):. PubMed ID: 27940602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
